DARIFENACIN 7.5 mg/1
DARIFENACIN · TABLET, EXTENDED RELEASE · Alembic Pharmaceuticals Limited
No Recall History
Plain English
DARIFENACIN is a tablet, extended release containing darifenacin at 7.5 mg/1, taken oral. Manufactured by Alembic Pharmaceuticals Limited.
Key Facts
- Brand Name
- DARIFENACIN
- Generic Name
- DARIFENACIN
- NDC Code (Product)
46708-223- Manufacturer
- Alembic Pharmaceuticals Limited
- Strength
- 7.5 mg/1
- Dosage Form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- ANDA207681
- Marketing Start
- 12/12/2017
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
drug ineffective183 reports
herpes zoster136 reports
peripheral swelling135 reports
pneumonia viral117 reports
arthralgia113 reports
synovitis107 reports
anaemia102 reports
fibromyalgia100 reports
arthritis98 reports
joint swelling97 reports
Frequently Asked Questions
What is DARIFENACIN used for?
DARIFENACIN contains DARIFENACIN. It is a tablet, extended release taken oral. Consult your doctor for specific uses.
Is DARIFENACIN a controlled substance?
DARIFENACIN is not classified as a controlled substance by the DEA.
What is the generic name for DARIFENACIN?
The generic name for DARIFENACIN is DARIFENACIN. There are 9 other brand versions of DARIFENACIN.
What is the NDC code for DARIFENACIN 7.5 mg/1?
The NDC (National Drug Code) for DARIFENACIN 7.5 mg/1 is 46708-223, listed by Alembic Pharmaceuticals Limited.